This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07111/identifier/pdb/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07111/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07111/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07111/identifier/drugbank/

Statements

Subject Item
n2:DB07111
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07111 n12:DB07111
dcterms:title
(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid
adms:identifier
n8:DB07111 n9:99443582 n10:4HD n11:24875301
n5:IUPAC-Name
n6:271B4AEF-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4AF5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4AF4-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4AF1-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4AF2-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4AF3-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4AED-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4AEE-363D-11E5-9242-09173F13E4C5 n6:271B4AEB-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4AEC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4AFB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4AFC-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4AF6-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4AF7-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4AF9-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4AF8-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4AFA-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4B01-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4B03-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4B04-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4B00-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4AFF-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4B02-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4AF0-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4AFD-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4AFE-363D-11E5-9242-09173F13E4C5